Gaelle R. B.
- Country
- France
- Department
- Pneumology Department
Research Overview
- Morning versus afternoon pembrolizumab administration with carboplatin-pemetrexed in stage IV non-squamous NSCLC: randomized phase III trial
- Evaluation of Adjuvant Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin in High-Risk Stage I/IIA Non-Squamous NSCLC Post-Resection
- Phase III Randomized Study of Immunotherapy and Local Ablative Treatments in Oligometastatic NSCLC: Evaluating Carboplatin, Ipilimumab, and Drug Combination
Data & Insights
Has run more than one trial at 46 of 159 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in treating advanced forms of non-small cell lung cancer (NSCLC), with particular focus on nonsquamous NSCLC variants and cases involving specific genetic markers.
- Metastatic Disease Management
- ROS1-Rearranged NSCLC
- Stage III/IV NSCLC
Precision Oncology
Expertise in targeted therapeutic approaches for lung cancer, particularly focusing on treatments for patients with specific genetic alterations and those who have undergone prior immunotherapy.
- Molecular-Targeted Therapies
- Immunotherapy Response
- Biomarker-Driven Treatment
Special Patient Populations
Dedicated focus on developing treatment strategies for elderly and frail patients with advanced lung cancer, addressing specific therapeutic needs of vulnerable populations.
- Elderly Patient Care
- Performance Status Assessment
- Treatment Adaptation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.